Exenatide more effective than insulinglargine in patients with type 2 diabetes

February 2011
Australian Journal of Pharmacy;Feb2011, Vol. 92 Issue 1089, p71
Case Study
The article presents a case study on the efficacy of exenatide on patients with type 2 diabetes. In the study, exenatide was compared with insulin gargine in adults with type 2 diabetes who had subtimum glycaemic control despite use of maximum tolerated doses of blood-glucose-lowering drugs for three months longer. It highlights the importance of exenatide on patients who has a risk of hypoglycaemia, weight loss.


Related Articles

  • Hypoglycaemia exacts extra costs in Canada.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p7 

    The article discusses research on the association of hypoglycemia with medication, discontinuation and costs in type 2 diabetes mellitus patients in Canada, referencing a study by M. Bron and colleagues presented at the 70th Annual Scientific Sessions of the American Diabetes Association.

  • Intensive blood glucose control for type 2 diabetes: meta-analysis.  // Africa Health;Mar2012, Vol. 34 Issue 3, p59 

    The article reports on a meta-analysis of intensive blood glucose control for type 2 diabetes, which found that intensive control could not minimize all-cause mortality, however, can increase the risk of severe hypoglycaemia by about 30%.

  • Antibacterials/insulin detemir/omeprazole interaction.  // Reactions Weekly;8/1/2013, Issue 1463, p9 

    The article presents a case study of an 82-year-old man with hypoglycaemia, which developed during treatment with amoxicillin, clarithromycin, omeprazole and insulin detemir for type 2 diabetes.

  • PEDIATRIC MANAGEMENT PROBLEMS. Belkengren, Richard; Sapala, Shirley // Pediatric Nursing;Mar/Apr2000, Vol. 26 Issue 2, p182 

    Presents the case of a 14-year-old female with Type I diabetes. Social and family history; Factors that contributed to the occurrence of hypoglycemia; Treatment for the disease.

  • A Qualitative Study of Perceived Responsibility and Self-Blame in Type 2 Diabetes: Reflections of Physicians and Patients. Beverly, Elizabeth; Ritholz, Marilyn; Brooks, Kelly; Hultgren, Brittney; Lee, Yishan; Abrahamson, Martin; Weinger, Katie // JGIM: Journal of General Internal Medicine;Sep2012, Vol. 27 Issue 9, p1180 

    BACKGROUND: Despite new treatment therapies and the emphasis on patient activation, nearly 50 % of diabetes patients have hemoglobin A levels above target. Understanding the impact of unmet treatment goals on the physician-patient relationship is important for maintaining quality care in...

  • THE THERAPEUTIC EFFECTS OF BIPHASIC INSULIN ASPART ON PATIENTS WITH DIABETES TYPE 2. Mujanović-Narančić, Alma // Medical Journal;abr-jun2011, Vol. 17 Issue 2, p113 

    Diabetes mellitus is a chronic and cureless disease but with an adequate treatment it can significantly improve the quality of life and extend the life expectancy. Within the treatment of Diabetes mellitus type 2 the therapy with biphasic insulin is accepted. The aims of this research are the...

  • U500 Regular Insulin Use in Insulin-Resistant Type 2 Diabetic Veteran Patients. Kelly, Kevin; Guerra, Patricia; George, Karen // Endocrine Practice;Jan2012, Vol. 18 Issue 1, p34 

    Objective: To evaluate the use of U500 regular insulin therapy in insulin-resistant patients with type 2 diabetes mellitus who were previously treated with high-dosage U100 insulin regimens.Methods: At a large Veterans Affairs medical center, a retrospective chart review was performed of all...

  • Impact of Race/Ethnicity on the Efficacy and Safety of Commonly Used Insulin Regimens: A Post Hoc Analysis of Clinical Trials in Type 2 Diabetes Mellitus. Jaime Davidson; Lyndon Lacaya; Honghua Jiang; Cory Heilmann; Jamie Scism-Bacon; Jeffrey Gates; Jeffrey Jackson // Endocrine Practice;Sep2010, Vol. 16 Issue 5, p818 

    Objective: To explore the impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens in patients with type 2 diabetes mellitus.Methods: In this post hoc analysis, pooled data from 11 multinational clinical trials involving 1455 patients with type 2 diabetes were used...

  • RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes (RABBIT 2 Trial). Smiley, Dawn D.; Zisman, Ariel; Prieto, Luz M.; Ceron, Miguel; Palacio, Andres; Puig, Alvaro; Mejia, Roberto; Umpierrez, Guillermo E. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA50 

    The association of inpatient hyperglycemia and poor clinical outcome is well established. Few studies have focused on the optimal management of hyperglycemia in non-ICU patients with type 2 diabetes mellitus (T2DM). Accordingly, we conducted a prospective, randomized multicenter trial to compare...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics